Looking to create new playbook against autoimmune diseases, startup grows $70M round

The way Genentech Inc. and other drug developers broke down cancer to get treatments to fit patients' tumors, and how heart drug maker Myokardia Inc. zeroed in on narrow subsets of heart disease to get the right drug to the right person, a new California drug maker is emerging with $70 million to bring a new sharpened focus to autoimmune diseases. Who better to lead Esker Therapeutics Inc. than June Lee, a biotech veteran who spent time at Genentech and Myokardia? For the past year and a half,…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news